Endomag: Going beyond the horizons
Cancer healthcare company Endomag, founded in 2007 as a spin-out from the University College London (UCL) and the University of Houston, has appointed Peter Keen as non-executive director. Keen will focus on supporting the company as it further extends its international reach.
A chartered accountant by trade, Keen has over 30 years experience in the management and financing of life science businesses. He founded the technology investment firm Cambridge Innovation Capital and has served on the board of many private and public companies. Currently, Keen is a director of both MRC Technology Limited and the Biotechnology Growth Trust plc.
Previously, he was the senior independent director of Abcam plc and was a co-founder of Chiroscience Group plc, where he led the £102m initial public offering. Keen was also a co-founder of the venture capital firm Merlin Biosciences, and, more recently, venture partner with the technology VC DFJ Esprit.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium